272 related articles for article (PubMed ID: 32476491)
1. Polymeric nanostructure vaccines: applications and challenges.
Simón-Vázquez R; Peleteiro M; González-Fernández Á
Expert Opin Drug Deliv; 2020 Jul; 17(7):1007-1023. PubMed ID: 32476491
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers.
Mishra N; Goyal AK; Tiwari S; Paliwal R; Paliwal SR; Vaidya B; Mangal S; Gupta M; Dube D; Mehta A; Vyas SP
Expert Opin Ther Pat; 2010 May; 20(5):661-79. PubMed ID: 20345332
[TBL] [Abstract][Full Text] [Related]
3. Nanovaccine: an emerging strategy.
Das A; Ali N
Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.
Bolhassani A; Javanzad S; Saleh T; Hashemi M; Aghasadeghi MR; Sadat SM
Hum Vaccin Immunother; 2014; 10(2):321-32. PubMed ID: 24128651
[TBL] [Abstract][Full Text] [Related]
5. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.
Dykman LA
Expert Rev Vaccines; 2020 May; 19(5):465-477. PubMed ID: 32306785
[TBL] [Abstract][Full Text] [Related]
6. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in vaccine delivery.
Cordeiro AS; Alonso MJ
Pharm Pat Anal; 2016; 5(1):49-73. PubMed ID: 26667309
[TBL] [Abstract][Full Text] [Related]
8. Nanoengineering of vaccines using natural polysaccharides.
Cordeiro AS; Alonso MJ; de la Fuente M
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1279-93. PubMed ID: 26049133
[TBL] [Abstract][Full Text] [Related]
9. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
10. Vaccine adjuvants: smart components to boost the immune system.
Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
[TBL] [Abstract][Full Text] [Related]
11. DNA Nanostructures: Self-Adjuvant Carriers for Highly Efficient Subunit Vaccines.
Shen F; Wang H; Liu Z; Sun L
Angew Chem Int Ed Engl; 2024 Jan; 63(2):e202312624. PubMed ID: 37737971
[TBL] [Abstract][Full Text] [Related]
12. Flagellin as a vaccine adjuvant.
Cui B; Liu X; Fang Y; Zhou P; Zhang Y; Wang Y
Expert Rev Vaccines; 2018 Apr; 17(4):335-349. PubMed ID: 29580106
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanogels as vaccine delivery systems.
Ferreira SA; Gama FM; Vilanova M
Nanomedicine; 2013 Feb; 9(2):159-73. PubMed ID: 22772049
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
Gupta RK; Chang AC; Siber GR
Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
[TBL] [Abstract][Full Text] [Related]
15. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
Leroux-Roels G
Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
[TBL] [Abstract][Full Text] [Related]
16. An overview on the role of silica-based materials in vaccine development.
Navarro-Tovar G; Palestino G; Rosales-Mendoza S
Expert Rev Vaccines; 2016 Nov; 15(11):1449-1462. PubMed ID: 27160927
[TBL] [Abstract][Full Text] [Related]
17. Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
Zhang L; Yang W; Hu C; Wang Q; Wu Y
Int J Nanomedicine; 2018; 13():2973-2987. PubMed ID: 29861631
[TBL] [Abstract][Full Text] [Related]
18. Liposomal adjuvants for human vaccines.
Alving CR; Beck Z; Matyas GR; Rao M
Expert Opin Drug Deliv; 2016 Jun; 13(6):807-16. PubMed ID: 26866300
[TBL] [Abstract][Full Text] [Related]
19. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
20. Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies.
Hartwell BL; Antunez L; Sullivan BP; Thati S; Sestak JO; Berkland C
J Pharm Sci; 2015 Feb; 104(2):346-61. PubMed ID: 25447598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
